California State Teachers Retirement System (CalSTRS)’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-70,661
| Closed | -$342K | – | 3163 |
|
|
2020
Q1 | $342K | Buy |
70,661
+818
| +1% | +$5.3K | ﹤0.01% | 2280 |
|
|
2019
Q4 | $742K | Hold |
69,843
| – | – | ﹤0.01% | 2139 |
|
|
2019
Q3 | $727K | Buy |
69,843
+8,164
| +13% | +$107K | ﹤0.01% | 2115 |
|
|
2019
Q2 | $945K | Buy |
61,679
+2,438
| +4% | +$35.3K | ﹤0.01% | 2005 |
|
|
2019
Q1 | $761K | Buy |
59,241
+14,958
| +34% | +$169K | ﹤0.01% | 2086 |
|
|
2018
Q4 | $421K | Buy |
44,283
+1,015
| +2% | +$13.2K | ﹤0.01% | 2383 |
|
|
2018
Q3 | $718K | Buy |
43,268
+977
| +2% | +$15.7K | ﹤0.01% | 2237 |
|
|
2018
Q2 | $679K | Buy |
42,291
+1,842
| +5% | +$32.9K | ﹤0.01% | 2292 |
|
|
2018
Q1 | $619K | Buy |
40,449
+4,854
| +14% | +$75.7K | ﹤0.01% | 2262 |
|
|
2017
Q4 | $555K | Sell |
35,595
-221
| -0.6% | -$2.96K | ﹤0.01% | 2350 |
|
|
2017
Q3 | $398K | Sell |
35,816
-4,233
| -11% | -$39.8K | ﹤0.01% | 2530 |
|
|
2017
Q2 | $368K | Sell |
40,049
-2,100
| -5% | -$17.5K | ﹤0.01% | 2652 |
|
|
2017
Q1 | $360K | Buy |
42,149
+7,400
| +21% | +$67.4K | ﹤0.01% | 2648 |
|
|
2016
Q4 | $372K | Sell |
34,749
-900
| -3% | -$10.9K | ﹤0.01% | 2668 |
|
|
2016
Q3 | $386K | Buy |
35,649
+300
| +0.8% | +$2.44K | ﹤0.01% | 2628 |
|
|
2016
Q2 | $239K | Buy |
35,349
+2,019
| +6% | +$12.7K | ﹤0.01% | 2858 |
|
|
2016
Q1 | $155K | Buy |
33,330
+4,396
| +15% | +$21.5K | ﹤0.01% | 2858 |
|
|
2015
Q4 | $183K | Buy |
28,934
+502
| +2% | +$4.07K | ﹤0.01% | 2876 |
|
|
2015
Q3 | $251K | Sell |
28,432
-100
| -0.4% | -$1.05K | ﹤0.01% | 2806 |
|
|
2015
Q2 | $336K | Buy |
28,532
+1,479
| +5% | +$20.5K | ﹤0.01% | 2806 |
|
|
2015
Q1 | $391K | Buy |
27,053
+5,700
| +27% | +$87.2K | ﹤0.01% | 2604 |
|
|
2014
Q4 | $364K | Buy |
21,353
+91
| +0.4% | +$1.31K | ﹤0.01% | 2678 |
|
|
2014
Q3 | $265K | Buy |
21,262
+221
| +1% | +$2.72K | ﹤0.01% | 2799 |
|
|
2014
Q2 | $309K | Buy |
21,041
+3,600
| +21% | +$55.2K | ﹤0.01% | 2781 |
|
|
2014
Q1 | $355K | Hold |
17,441
| – | – | ﹤0.01% | 2625 |
|
|
2013
Q4 | $342K | Buy |
17,441
+1,100
| +7% | +$29.4K | ﹤0.01% | 2655 |
|
|
2013
Q3 | $740K | Buy |
16,341
+400
| +3% | +$13K | ﹤0.01% | 2122 |
|
|
2013
Q2 | $380K | Buy |
+15,941
| New | +$254K | ﹤0.01% | 2472 |
|
California State Teachers Retirement System (CalSTRS)'s STML Position: Q2 2020 in Review
California State Teachers Retirement System (CalSTRS) sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 70,661 shares — an estimated $342K sold.
California State Teachers Retirement System (CalSTRS) first reported a position in STML in Q2 2013 and held it in 28 quarters. The position peaked at $945K in Q2 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- California State Teachers Retirement System (CalSTRS) reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 70,661 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $342K.
- California State Teachers Retirement System (CalSTRS) first reported a position in Stemline Therapeutics, Inc. in Q2 2013 and held it in 28 quarters.
- California State Teachers Retirement System (CalSTRS)'s Stemline Therapeutics, Inc. position peaked at $945K in Q2 2019.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2020, filed 17 Aug 2020.